These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16857204)

  • 1. Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach.
    Tziakas DN; Chalikias GK; Kaski JC; Kekes A; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris AX; Hatseras DI
    Atherosclerosis; 2007 Jul; 193(1):196-203. PubMed ID: 16857204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome.
    Chalikias GK; Tziakas DN; Kaski JC; Kekes A; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris AX; Hatseras DI
    Int J Cardiol; 2007 May; 117(3):333-9. PubMed ID: 16859776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-18: interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome.
    Chalikias GK; Tziakas DN; Kaski JC; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris A; Hatseras DI
    Atherosclerosis; 2005 Sep; 182(1):135-43. PubMed ID: 16115484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome.
    Cavusoglu E; Marmur JD; Hojjati MR; Chopra V; Butala M; Subnani R; Huda MS; Yanamadala S; Ruwende C; Eng C; Pinsky DJ
    Am J Med; 2011 Aug; 124(8):724-30. PubMed ID: 21787901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome.
    Kilic T; Ural D; Ural E; Yumuk Z; Agacdiken A; Sahin T; Kahraman G; Kozdag G; Vural A; Komsuoglu B
    Heart; 2006 Aug; 92(8):1041-6. PubMed ID: 16547209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes.
    Frasure-Smith N; Lespérance F; Irwin MR; Sauvé C; Lespérance J; Théroux P
    Biol Psychiatry; 2007 Aug; 62(4):302-8. PubMed ID: 17210140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.
    O'Malley T; Ludlam CA; Riemermsa RA; Fox KA
    Eur Heart J; 2001 Jul; 22(14):1226-34. PubMed ID: 11440495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Haemostatic and inflammation markers in acute coronary syndromes and its relationship with adverse cardiovascular events].
    Díaz CJ; Núñez AC; Flores MI; Arcaute HD; Archondo T
    Arch Cardiol Mex; 2006; 76(4):366-75. PubMed ID: 17315612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Thromb Haemost; 2005 Nov; 94(5):1077-83. PubMed ID: 16363252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
    Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
    Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes.
    Heeschen C; Dimmeler S; Hamm CW; Fichtlscherer S; Boersma E; Simoons ML; Zeiher AM;
    Circulation; 2003 Apr; 107(16):2109-14. PubMed ID: 12668510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events.
    Palikhe A; Sinisalo J; Seppänen M; Haario H; Meri S; Valtonen V; Nieminen MS; Lokki ML
    Am J Cardiol; 2007 Apr; 99(7):890-5. PubMed ID: 17398178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.
    Heeschen C; Dimmeler S; Hamm CW; Fichtlscherer S; Simoons ML; Zeiher AM;
    J Am Coll Cardiol; 2005 Jan; 45(2):229-37. PubMed ID: 15653020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
    Ridker PM; Hennekens CH; Buring JE; Rifai N
    N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome.
    Kilic T; Oner G; Ural E; Yumuk Z; Sahin T; Bildirici U; Acar E; Celikyurt U; Kozdag G; Ural D
    Atherosclerosis; 2009 Dec; 207(2):552-8. PubMed ID: 19523634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome.
    Kaski JC; Consuegra-Sanchez L; Fernandez-Berges DJ; Cruz-Fernandez JM; Garcia-Moll X; Marrugat J; Mostaza J; Toro-Cebada R; González-Juanatey JR; Guzmán-Martínez G;
    Atherosclerosis; 2008 Nov; 201(1):176-83. PubMed ID: 18336825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up.
    Hartford M; Wiklund O; Mattsson Hultén L; Perers E; Person A; Herlitz J; Hurt-Camejo E; Karlsson T; Caidahl K
    Int J Cardiol; 2006 Mar; 108(1):55-62. PubMed ID: 16516698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.